AI Assistant
Blog
Pricing
Log In
Sign Up
Phase I Study of MK-954, a New Angiotensin II Receptor Antagonist. Results of Multiple Oral Administration.
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
